Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



Randomized Trial of Gilteritinib vs Midostaurin in FLT3 Mutated Acute Myeloid Leukemia (AML).

Leukemia

Leukemia
II
Kishtagari, Ashwin
NCT03836209
VICCHEM1957

A Phase 3 Randomized Trial for Patients with de novo AML Comparing Standard Therapy Including Gemtuzumab Ozogamicin (GO) to CPX-351 with GO, and the Addition of the FLT3 Inhibitor Gilteritinib for Patients with FLT3 Mutations

Multiple Cancer Types

Leukemia, Pediatric Leukemia, Pediatrics
III
Zarnegar-Lumley, Sara
NCT04293562
COGAAML1831

To learn more about any of our clinical
trials, call 615-936-8422.